Article: Form4Oracle: Insider Trading Report: Par Pharmaceutical Companies, Inc. (PRX).

M2 PRESSWIRE-5 October 2007-Form 4 Oracle: Form4Oracle: Insider Trading Report: Par Pharmaceutical Companies, Inc. (PRX)(C)1994-2007 M2 COMMUNICATIONS LTD

RDATE:05092007

Several insiders at Par Pharmaceutical Companies, Inc. (PRX) have reported buying more than $691.31K today as the stock was trading near its 52-week low:

- Abernathy John D, Director: reported buying $91.24K

- Martino Gerard, EVP & Chief Operating Officer: reported buying $49.28K

- Lepore Patrick G, Chairman, CEO and President: reported buying $550.80K

Over the last four weeks insiders at Par Pharmaceutical Companies, Inc. (PRX) have bought more ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!